Roberto Castello

Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation¹

Paolo Moghetti, Roberto Castello, Carlo Negri et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 659 citations · Full text

Metabolic Disorder, Gynecology, Polycystic Ovary Syndrome +19

The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.

Paolo Moghetti, Flavia Tosi, Roberto Castello et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 232 citations · Full text

Hormonal Contraceptive, Gynecology, Ovarian Cancer +19

Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.

Paolo Moghetti, Roberto Castello, Carlo Negri et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 185 citations · Full text

17,20-Lyase Activity, Female Reproductive Function, Saline Infusion +21

The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors

Iñigo Landa, Sergio Ruiz‐Llorente, Cristina Montero‐Conde et al. · PLoS Genetics · 2009 · 162 citations · Full text

Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, Followed by Open, Long-Term Clinical Evaluation

Paolo Moghetti, Roberto Castello, Carlo Negri et al. · Obstetrical & Gynecological Survey · 2000 · 159 citations

Metabolic Disorder, Gynecology, Polycystic Ovary Syndrome +17